10342-47-9

Basic information

• Product Name: L-Phenylalanine, N-L-valyl-, methyl ester, monohydrochloride
• CAS NO: 10342-47-9
• Molecular Formula: C15H22N2O3.ClH
• Molecular Weight: 314.812
• Mol File: 10342-47-9.mol

Chemical Properties

• CAS DataBase Reference: L-Phenylalanine, N-L-valyl-, methyl ester, monohydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalanine, N-L-valyl-, methyl ester, monohydrochloride(10342-47-9)
• EPA Substance Registry System: L-Phenylalanine, N-L-valyl-, methyl ester, monohydrochloride(10342-47-9)

Safety Data

• Hazardous Substances Data: 10342-47-9(Hazardous Substances Data)

Upstream product

• 78581-05-2 For-Val-Phe-OMe 
• 116763-17-8 (S)-3-methyl-2-(1-pyrrolyl)butyryl-L-phenylalanine methyl ester 
• 67-56-1 methanol 
• 3918-92-1 L-valyl L-phenylalanine 
• 72-18-4 L-valine 
• 63813-68-3 (2S)-3-methyl-2-(1H-pyrrol-1-yl)butanoic acid 
• 4289-97-8 N-formyl-L-valine 
• 20902-47-0 N-tert-butoxycarbonyl-L-valyl-L-phenylalanine methyl ester 
• 141468-55-5 4-isopropyl-2,5-dioxo-oxazolidine-3-carboxylic acid-tert-butyl ester 
• 7524-50-7 methyl (2S)-2-amino-3-phenylpropanoate hydrochloride 
• 63-91-2 L-phenylalanine 

Downstream Products

• 73604-36-1 Z-Leu-Val-Phe-OCH₃ 
• 78581-09-6 Z-Gly-Leu-Val-Phe-OMe 
• 77119-89-2 (S)-2-[(S)-2-((2S,3S)-3-tert-Butoxycarbonylamino-2-hydroxy-5-methyl-hexanoylamino)-3-methyl-butyrylamino]-3-phenyl-propionic acid methyl ester 
• 77119-89-2 (S)-2-[(S)-2-((2R,3S)-3-tert-Butoxycarbonylamino-2-hydroxy-5-methyl-hexanoylamino)-3-methyl-butyrylamino]-3-phenyl-propionic acid methyl ester 
• 81322-86-3 (S)-2-{(S)-2-[(2S,3S)-3-((S)-2-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-2-hydroxy-5-methyl-hexanoylamino]-3-methyl-butyrylamino}-3-phenyl-propionic acid methyl ester 
• 81322-86-3 (S)-2-{(S)-2-[(2R,3S)-3-((S)-2-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-2-hydroxy-5-methyl-hexanoylamino]-3-methyl-butyrylamino}-3-phenyl-propionic acid methyl ester 
• 91425-27-3 <5(S)--7-methyl-3(E)-octenoyl>-L-valyl-L-phenylalanine methyl ester 
• 24210-21-7 Z-Leu-Leu-Val-Phe-OCH₃ 
• 73604-37-2 Leu-Val-Phe-OCH₃*HCl 
• 73604-34-9 L-2-hydroxy-3-phenylpropanoyl-Leu-Val-Phe-OCH₃ 
• 24210-22-8 Leu-Leu-Val-Phe-OMe hydrochloride 
• 73604-33-8 D-α-Hydroxyisovaleryl-Leu-Val-Phe-OCH3 
• 73604-33-8 L-α-hydroxyisovaleryl-Leu-Val-Phe-OCH3 
• 73604-32-7 D-α-hydroxyisocaproyl-Leu-Val-Phe-OCH3 

Relevant articles and documents

Site-Selective Acylation of Pyranosides with Oligopeptide Catalysts

Herein, we report the oligopeptide-catalyzed site-selective acylation of partially protected monosaccharides. We identified catalysts that invert site-selectivity compared to N-methylimidazole, which was used to determine the intrinsic reactivity, for 4,6

SMALL MOLECULE MODULATORS OF PCSK9 AND METHODS OF USE THEREOF

A compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, or racemic mixture or stereoisomer thereof, and methods for preventing or treating an LDL-cholesterol-related disease or disorder using such compound(s), and kits and comp

Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors

Aminopeptidase N (APN/CD13) is one of the essential proteins for tumour invasion, angiogenesis and metastasis as it is over-expressed on the surface of different tumour cells. Based on our previous work that L-isoserine dipeptide derivatives were potent APN inhibitors, we designed and synthesized L-isoserine tripeptide derivatives as APN inhibitors. Among these compounds, one compound 16l (IC50=2.51±0.2 M) showed similar inhibitory effect compared with control compound Bestatin (IC50=6.25±0.4 M) and it could be used as novel lead compound for the APN inhibitors development as anticancer agents in the future.

Environmentally benign peptide synthesis using liquid-assisted ball-milling: Application to the synthesis of Leu-enkephalin

This paper describes an original methodology for peptide bond synthesis avoiding toxic solvents and reactants. Ball-milling stoichiometric amounts of Boc-protected α-amino acid N-carboxyanhydrides (Boc-AA-NCA) or Boc-protected α-amino acid N-hydroxysuccin

Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: A strategy for the design of peptidase inhibitors

The cholecystokinin-8 (CCK-8)-inactivating peptidase is a serine peptidase which has been shown to be a membrane-bound isoform of tripeptidyl peptidase II (EC 3.4.14.10). It cleaves the neurotransmitter CCK-8 sulfate at the Met-Gly bond to give Asp-Tyr(SO3H)-Met-OH + Gly-Trp-Met-Asp-Phe-NH2. In seeking a reversible inhibitor of this peptidase, the enzymatic binding subsites were characterized using a fluorimetric assay based on the hydrolysis of the artificial substrate Ala-Ala-Phe-amidomethylcoumarin. A series of di- and tripeptides having various alkyl or aryl side chains was studied to determine the accessible volume for binding and to probe the potential for hydrophobic interactions. From this initial study the tripeptides Ile-Pro-Ile-OH (K(i) = 1 μM) and Ala-Pro-Ala-OH (K(i) = 3 μM) and dipeptide amide Val-Nvl-NHBu (K(i) = 3 μM) emerged as leads. Comparison of these structures led to the synthesis of Val-Pro-NHBu (K(i) = 0.57 μM) which served for later optimization in the design of butabindide, a potent reversible competitive and selective inhibitor of the CCK-8-inactivating peptidase. The strategy for this work is explicitly described since it illustrates a possible general approach for peptidase inhibitor design.

Peptide Synthesis Using the Pyrrole Ring as an Amino Protecting Group

The utility of a pyrrole ring as an amino protecting group for amino acids in peptide synthesis has been studied.The N-termini of various amino acids (1) were protected with a pyrrole ring by treatment with 2,5-dimethoxytetrahydrofuran (10) to give 2-substituted 2-(1-pyrrolyl)acetic acids (11).The peptide bond between (11) and amino acid methyl ester (2) was formed using N,N'-dicyclohexylcarbodiimide, and the pyrrole ring was cleaved by ozonolysis and hydrolysis without the cleavage of a peptide bond to give the corresponding dipeptide compounds (26) in good yields.

INVESTIGATION ON COUPLING PEPTIDES TO AMINOMETHYL POLYMERS

Different peptide bond forming methods for attachment of model peptides to aminomethyl polymers have been compared.It has been observed that the yield of reaction depends on such features of polymer as quantity of functional groups and degree of its cross-linking.The sequential Edman degradation of a model peptide corresponding to 5 to 9 fragment of substance P was performed by the solid-phase technique.